HEIDELBERG, Germany, December 25, 2024 /PRNewswire/ — European Biomedical Wellbeing Group (EWBG) launched a new research initiative focused on Klothoa protein with transformative potential in longevity medicine. Led by Professor Dr. Mike Chanthis project will explore the role of Klotho in the fight against age-related diseases and its ability to regenerate critical organs, including the brain, kidneysAnd heart.
Klothoidentified in 1997, appears to be a key protein in longevity and regenerative medicine. It plays a central role in the regulation of oxidative stress, mineral metabolism and inflammation. The research will examine how increasing Klotho levels could help fight chronic diseases such as neurodegenerative diseases, kidney failureAnd heart diseaseultimately improving service life and extending service life.
“Klotho represents the next frontier in longevity medicine,” said Teacher Mike Chanchief scientist at EWBG. “Our research aims to understand how Klotho affects aging and how we can use it to treat chronic diseases long associated with aging.”
Areas of Research Interest
The new initiative will focus on three main research areas:
- Neurological health: Studying the neuroprotective effects of Klotho and its potential to slow cognitive decline in diseases like Alzheimer’s And Parkinson’s.
- Kidney function: Examine the role of Klotho in the regulation of mineral metabolism and its regenerative potential in treatment chronic kidney disease (CKD).
- Cardiovascular health: Study the influence of Klotho on vascular function and its ability to prevent vascular calcificationa key contributor to heart disease.
This research builds on existing collaborations at EWBGwhere leading scientists focus on advancing Klotho-based therapies for regenerative health.
Klotho: a potential breakthrough in longevity medicine
Klotho is gaining attention for its ability to regenerate tissue and reverse damage caused by age-related diseases. Contrary to NAD+which primarily improves cellular metabolism and energy production, Klotho offers a wider range of therapeutic applications, including tissue regeneration, improved cognitive function and cardiovascular health.
As we age, Klotho levels naturally decline, leading to conditions such as cognitive decline, heart disease, and kidney failure. Research suggests that restoring Klotho levels can reverse the effects of oxidative stress, inflammation and cellular senescence, providing new treatment opportunities for a range of age-related diseases.
Teacher Mike Chan: Leading the charge in Klotho research
Teacher Mike Chana leading expert in stem cell therapy And longevity medicineis spearheading this revolutionary initiative to EWBG. His extensive experience in bio-regenerative medicine positions him as a key figure in exploring Klotho’s potential to revolutionize the treatment of age-related diseases. Through FCTIsubsidiary of EWBG, Professor Chan and his team are developing therapies that combine stem cell technology And Klotho Proteins to stimulate tissue regeneration in the brain, kidneysAnd heart.
“By harnessing the regenerative properties of Klotho, we hope to combat chronic diseases that were previously incurable,” said Professor Chan. “Our ultimate goal is to improve quality of life and provide lasting solutions to people affected by age-related diseases.”
The Future of Klotho in Longevity Medicine
The future of Klotho-based therapies it looks promising, with Teacher Mike Chan And EWBG at the forefront of this innovative field. As more research is conducted, Klotho is expected to play a central role in advancing longevity medicineproposing a new approach to the treatment of aging and chronic diseases. The potential applications of Klotho are vast, from treatment of neurodegenerative diseases has renal regeneration And cardiovascular health.
With strong research partnerships, significant funding and ongoing clinical trials, Klotho is poised to become a cornerstone of longevity medicinetransforming the way we approach aging and illness. Teacher Mike Chan’s leadership ensures that this promising protein will soon offer new hope to those seeking longer, healthier lives.
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/european-wellness-biomedical-group-announces-new-klotho-research-initiative-led-by-prof-mike-chan-302338977.html
SOURCE European Biomedical Wellness Group
